$XSPA Everyone is focused too much on the testing and not enough on the fact that right now, this company is already pivoting to a permanent healthcare model. Xprescheck will likely not be handling the bulk of the airport testing nationwide, but will be the faster, more convenient option wherever they setup. They don't need to be the only player, as their real goal is to build minute clinics that will be permanent fixtures. The pandemic shed light on the need for these facilities in airports and once it passes, will simply be a means to an end. This will likely have some good runs in the next month and the next year, but longer-term, if this works as planned, it should be a nice growth stock, and a good candidate for a buyout.